Overview
- Sales began Monday with the 1.5 mg starter dose in stock at more than 70,000 pharmacies such as CVS and Costco and through partners including Ro, LifeMD, Weight Watchers, GoodRx and NovoCare Pharmacy, with higher strengths due by week’s end.
- Self-pay pricing is $149 per month for 1.5 mg and for 4 mg through April 15 before rising to $199, while 9 mg and 25 mg cost $299; some insured patients may pay as little as $25.
- The $149 entry price also appears on the TrumpRx direct-to-consumer platform under a November agreement with the White House.
- The FDA cleared the daily pill in late December with a label to manage weight and to reduce major cardiovascular events in adults with obesity and established heart disease.
- Trial data showed average weight loss of about 17% among patients who stayed on treatment (about 14% including discontinuations), though the pill must be taken on an empty stomach with a 30‑minute wait and commonly causes gastrointestinal side effects; Eli Lilly’s competing oral GLP‑1 remains under FDA review.